These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14751229)

  • 21. Effects of L-histidine and its structural analogues on human N-myristoyltransferase activity and importance of EEVEH amino acid sequence for enzyme activity.
    Raju RV; Datla RS; Warrington RC; Sharma RK
    Biochemistry; 1998 Oct; 37(42):14928-36. PubMed ID: 9778369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and biochemical studies establish that the fungicidal effect of a fully depeptidized inhibitor of Cryptococcus neoformans myristoyl-CoA:protein N-myristoyltransferase (Nmt) is Nmt-dependent.
    Lodge JK; Jackson-Machelski E; Higgins M; McWherter CA; Sikorski JA; Devadas B; Gordon JI
    J Biol Chem; 1998 May; 273(20):12482-91. PubMed ID: 9575206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of protein N-myristoylation: a therapeutic protocol in developing anticancer agents.
    Das U; Kumar S; Dimmock JR; Sharma RK
    Curr Cancer Drug Targets; 2012 Jul; 12(6):667-92. PubMed ID: 22463587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent inhibitor of N-myristoylation: a novel molecular target for cancer.
    Shrivastav A; Pasha MK; Selvakumar P; Gowda S; Olson DJ; Ross AR; Dimmock JR; Sharma RK
    Cancer Res; 2003 Nov; 63(22):7975-8. PubMed ID: 14633729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
    Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI
    Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of myristoyl CoA analogues and myristoyl peptides as inhibitors of myristoyl CoA:protein N-myristoyltransferase.
    Zheng GQ; Hu X; Cassady JM; Paige LA; Geahlen RL
    J Pharm Sci; 1994 Feb; 83(2):233-8. PubMed ID: 8169796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action.
    Schlott AC; Holder AA; Tate EW
    ACS Infect Dis; 2018 Apr; 4(4):449-457. PubMed ID: 29363940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential activation of bovine brain N-myristoyltransferase(s) by a cytosolic activator.
    King MJ; Sharma RK
    Biochem Biophys Res Commun; 1995 Jul; 212(2):580-8. PubMed ID: 7626073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression, localization, and correlation of N-myristoyltransferase and its inhibitor in bovine eye.
    Shrivastav A; Pasha MK; Selvakumar P; Singh B; Sharma RK
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1674-9. PubMed ID: 15161825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of myristoyl CoA:protein N-myristoyltransferase activity by ion-exchange chromatography.
    Paige LA; Chafin DR; Cassady JM; Geahlen RL
    Anal Biochem; 1989 Sep; 181(2):254-8. PubMed ID: 2817389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of N-myristoyltransferase from Aspergillus fumigatus.
    Shimada T; Suzuki M; Katakura S
    Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):754-61. PubMed ID: 25849386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning, genomic organization, and biochemical characterization of myristoyl-CoA:protein N-myristoyltransferase from Arabidopsis thaliana.
    Qi Q; Rajala RV; Anderson W; Jiang C; Rozwadowski K; Selvaraj G; Sharma R; Datla R
    J Biol Chem; 2000 Mar; 275(13):9673-83. PubMed ID: 10734119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-myristoyltransferase: a novel target.
    Prasad KK; Toraskar MP; Kadam VJ
    Mini Rev Med Chem; 2008 Feb; 8(2):142-9. PubMed ID: 18289097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a polyhistidine-tagged form of human myristoyl-CoA: protein N-myristoyltransferase produced in Escherichia coli.
    McIlhinney RA; Patel PB; McGlone K
    Eur J Biochem; 1994 May; 222(1):137-46. PubMed ID: 8200338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.
    Sheng C; Ji H; Miao Z; Che X; Yao J; Wang W; Dong G; Guo W; Lü J; Zhang W
    J Comput Aided Mol Des; 2009 Jun; 23(6):375-89. PubMed ID: 19370313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyzing the substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase by co-expressing it with mammalian G protein alpha subunits in Escherichia coli.
    Duronio RJ; Rudnick DA; Adams SP; Towler DA; Gordon JI
    J Biol Chem; 1991 Jun; 266(16):10498-504. PubMed ID: 1903791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and characterization of yeast myristoyl CoA:protein N-myristoyltransferase.
    Towler DA; Adams SP; Eubanks SR; Towery DS; Jackson-Machelski E; Glaser L; Gordon JI
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2708-12. PubMed ID: 3106975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An assay for myristoyl-CoA: protein N-myristoyltransferase activity based on ion-exchange exclusion of [3H]myristoyl peptide.
    French SA; Christakis H; O'Neill RR; Miller SP
    Anal Biochem; 1994 Jul; 220(1):115-21. PubMed ID: 7978234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic activation of 2-substituted derivatives of myristic acid to form potent inhibitors of myristoyl CoA:protein N-myristoyltransferase.
    Paige LA; Zheng GQ; DeFrees SA; Cassady JM; Geahlen RL
    Biochemistry; 1990 Nov; 29(46):10566-73. PubMed ID: 2271666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.